MetaCap

Eaton Vance Tax-Advantage Global Dividend Opp (ETO) vs abrdn Life Sciences Investors (HQL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Eaton Vance Tax-Advantage Global Dividend Opp (ETO) has outperformed abrdn Life Sciences Investors (HQL) over the past year, losing 2.0% versus a loss of 8.5%. Over five years, ETO leads with a -11.7% price change compared with -22.8% for HQL. On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.3x vs 3.3x for Eaton Vance Tax-Advantage Global Dividend Opp).

abrdn Life Sciences Investors offers the higher dividend yield (12.42% vs 7.62%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ETO-2.05%HQL-8.51%
+37%+13%-11%
Nov 21, 20251 yearNov 20, 2026
ETO-16.47%HQL-24.98%
+12%-18%-47%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ETO versus HQL key metrics
MetricETOHQL
Share price$27.28$15.38
Market cap$447.07M—
1-day change-3.88%-3.81%
YTD return-10.12%-8.34%
1-year return-2.05%-8.51%
5-year return-11.74%-22.83%
P/E ratio (TTM)3.272.32
EPS (TTM)$8.33$6.64
Dividend yield7.62%12.42%
Annual dividend$2.08$1.91
52-week high$32.35$22.67
52-week low$25.68$15.35
Distance from 52-week high-15.67%-32.16%
Analyst consensusnone—
Average volume26.91K129.21K
Shares outstanding16.39M—
SectorFinanceFinance
IndustryInvestment ManagersInvestment Managers

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Eaton Vance Tax-Advantage Global Dividend Opp trades at a higher earnings multiple (3.3x vs 2.3x trailing P/E).
  • abrdn Life Sciences Investors offers a meaningfully higher dividend yield (12.42% vs 7.62%).

About Eaton Vance Tax-Advantage Global Dividend Opp

ETO stock →

Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund is a closed ended equity mutual fund launched and managed by Eaton Vance Management. It invests in public equity markets across the globe.

Finance · Investment Managers

About abrdn Life Sciences Investors

HQL stock →

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.

Finance · Investment Managers

ETO vs HQL FAQ

Which stock has performed better over the past year, ETO or HQL?

ETO returned -2.05% over the past 12 months, compared with -8.51% for HQL (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ETO or HQL?

HQL has the lower trailing P/E at 2.3, versus 3.3 for ETO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Eaton Vance Tax-Advantage Global Dividend Opp or abrdn Life Sciences Investors?

abrdn Life Sciences Investors has the higher yield at 12.42%, compared with 7.62% for Eaton Vance Tax-Advantage Global Dividend Opp.

Are Eaton Vance Tax-Advantage Global Dividend Opp and abrdn Life Sciences Investors in the same industry?

Yes. Both are classified in the Investment Managers industry within the Finance sector.

More comparisons